TIE1 and cervical carcinoma: To explore the mechanism of action of TIE1 in cervical cancer progression, we examined the potential TIE1-interacting proteins by immunoprecipitation (IP) and liquid chromatography coupled with tandem mass spectrometry (LC‒MS/MS) analysis in the TIE1-overexpressing HeLa cell line (Figure 3A).